Patent · US Active

Listeria-based adjuvants

US9463227B2 · kind B2 · utility

16Cited by

69References

15Claims

0Family size

Assignees

Advaxis, Inc. · US
The Trustees of the University of Pennsylvania · US
University of Georgia Research Foundation, Inc. · US

Inventors

John Rothman · Lebanon, US
Anu Wallecha · Yardley, US
Reshma Singh · Cambridge, US
Donald A. Harn · Pembroke, US
Yvonne Paterson · Philadelphia, US

Key dates

Filing date	Mar 12, 2012
Grant date	Oct 11, 2016
Priority date	—
Expiry date	Apr 3, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/523
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides methods and compositions for using Listeria monocytogenes as an adjuvant for enhancing immune responses in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.